- Home
- HUM vs BDX Comparison
HUM vs BDX Comparison
Compare HUM & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUM | BDX |
|---|---|---|
| Founded | 1961 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.0B | 48.2B |
| IPO Year | 2002 | 1998 |
Fundamental Metrics
Financial Performance| Metric | HUM | BDX |
|---|---|---|
| Price | $404.01 | $180.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 14 |
| Target Price | ★ $423.74 | $196.50 |
| AVG Volume (30 Days) | 712.7K | ★ 1.5M |
| Earning Date | 11-06-2026 | 11-05-2026 |
| Dividend Yield | 0.88% | ★ 2.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.83 | 1.59 |
| Revenue | ★ $129,664,000,000.00 | $21,840,000,000.00 |
| Revenue This Year | $25.51 | N/A |
| Revenue Next Year | $3.48 | $2.39 |
| P/E Ratio | ★ $41.07 | $113.43 |
| Revenue Growth | ★ 10.11 | 8.24 |
| 52 Week Low | $163.11 | $140.11 |
| 52 Week High | $428.88 | $213.08 |
Technical Indicators
Market Signals| Indicator | HUM | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 59.67 | 48.93 |
| Support Level | $385.22 | $175.20 |
| Resistance Level | $419.36 | $186.99 |
| Average True Range (ATR) | 12.76 | 3.80 |
| MACD | 1.44 | -0.54 |
| Stochastic Oscillator | 82.66 | 39.18 |
Price Performance
Historical ComparisonAbout HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About BDX Becton Dickinson and Company
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.